Pharmaceutical combinations

Details for Australian Patent Application No. 2009227918 (hide)

Owner Novartis International Pharmaceutical Ltd.

Inventors Wyllie, Michael Grant

Agent Spruson & Ferguson

Pub. Number AU-B-2009227918

Parent 2006202176

Filing date 23 October 2009

Wipo publication date 12 November 2009

Acceptance publication date 22 September 2011

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/497 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

Event Publications

5 November 2009 Complete Application Filed

12 November 2009 Application Open to Public Inspection

  Published as AU-B-2009227918

22 September 2011 Application Accepted

  Published as AU-B-2009227918

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009227919-A Locking Device

2009227917-Carbon oxide and/or sulfur oxide capture in a liquid environment